About
Basic Data Updated:
2 months agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500660 and on the National Stock Exchange(NSE) under GLAXO.
The Corporate was formerly known as British Drug Houses (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 180.00 cr and a paid-up capital of Rs 169.41 cr.
The Corporate currently has active open charges totaling ₹21.87 cr. It has already closed loans amounting to ₹130.00 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Glaxosmithkline Pharmaceuticals Limited India are Ajay Nadkarni as Company Secretary and Juby Chandy as Cfo. Renu Karnad, Sundaram Damodarannair, Manu Anand, and Six other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Financials of Glaxosmithkline Pharmaceuticals Limited
Glaxosmithkline Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.73% increase. The company also saw a substantial fall in profitability, with a 64.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.53%.
Corporate Structure
Unlock access to Glaxosmithkline Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Glaxosmithkline Pharmaceuticals Limited
Unlock and access historical data on people associated with Glaxosmithkline Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
Bhushan Akshikar
Managing DirectorAppointment Date: 01-Dec-2022
Status: Current
AN
Ajay Nadkarni Company SecretaryAppointment Date: 01-Nov-2001
Status: Current
JC
Juby Chandy CFOAppointment Date: 01-Apr-2022
Status: Current
Board Members(8)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Ltd. Creation Date: 13 Jul 1989 | ₹21.87 Cr | Open |
Uti Bank Ltd. Creation Date: 20 Sep 2004 | ₹130.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glaxosmithkline Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glaxosmithkline Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Schneider Electric India Private Limited
Active
29 years 6 months Sundaram Damodarannair is a mutual person
Recent activity within the organization
Annual General Meeting
Glaxosmithkline Pharmaceuticals Limited last Annual general meeting of members was held on 26 Jul 2023 as per latest MCA records.
26 Jul 2023Balance Sheet
Glaxosmithkline Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Manu Anand was appointed as a Director was appointed as a Director on 16 May 2022 & has been associated with this company since 2 years 3 months .
16 May 2022Director Appointment
Sunitha Maheshwari was appointed as a Director was appointed as a Director on 18 May 2020 & has been associated with this company since 4 years 3 months .
18 May 2020Director Appointment
Renu Sud Karnad was appointed as a Director was appointed as a Director on 01 Apr 2019 & has been associated with this company since 5 years 5 months .
01 Apr 2019
Frequently asked questions
What is the Incorporation or founding date of Glaxosmithkline Pharmaceuticals Limited?
